392 related articles for article (PubMed ID: 25324143)
21. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.
Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X
Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183
[TBL] [Abstract][Full Text] [Related]
22. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
23. The miR-379/miR-410 cluster at the imprinted Dlk1-Dio3 domain controls neonatal metabolic adaptation.
Labialle S; Marty V; Bortolin-Cavaillé ML; Hoareau-Osman M; Pradère JP; Valet P; Martin PG; Cavaillé J
EMBO J; 2014 Oct; 33(19):2216-30. PubMed ID: 25124681
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone.
Lehner B; Kunz P; Saehr H; Fellenberg J
BMC Cancer; 2014 Jul; 14():495. PubMed ID: 25005035
[TBL] [Abstract][Full Text] [Related]
25. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
[TBL] [Abstract][Full Text] [Related]
26. Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma.
Valdmanis PN; Roy-Chaudhuri B; Kim HK; Sayles LC; Zheng Y; Chuang CH; Caswell DR; Chu K; Zhang Y; Winslow MM; Sweet-Cordero EA; Kay MA
Oncogene; 2015 Jan; 34(1):94-103. PubMed ID: 24317514
[TBL] [Abstract][Full Text] [Related]
27. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
28. A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer.
Selth LA; Das R; Townley SL; Coutinho I; Hanson AR; Centenera MM; Stylianou N; Sweeney K; Soekmadji C; Jovanovic L; Nelson CC; Zoubeidi A; Butler LM; Goodall GJ; Hollier BG; Gregory PA; Tilley WD
Oncogene; 2017 Jan; 36(1):24-34. PubMed ID: 27270433
[TBL] [Abstract][Full Text] [Related]
29. The Upregulation of Genomic Imprinted DLK1-Dio3 miRNAs in Murine Lupus Is Associated with Global DNA Hypomethylation.
Dai R; Lu R; Ahmed SA
PLoS One; 2016; 11(4):e0153509. PubMed ID: 27070142
[TBL] [Abstract][Full Text] [Related]
30. Regulation of DLK1 by the maternally expressed miR-379/miR-544 cluster may underlie callipyge polar overdominance inheritance.
Gao YQ; Chen X; Wang P; Lu L; Zhao W; Chen C; Chen CP; Tao T; Sun J; Zheng YY; Du J; Li CJ; Gan ZJ; Gao X; Chen HQ; Zhu MS
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13627-32. PubMed ID: 26487685
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cell-cell adhesion in prostate cancer cells by microRNA-96 through upregulation of E-Cadherin and EpCAM.
Voss G; Haflidadóttir BS; Järemo H; Persson M; Catela Ivkovic T; Wikström P; Ceder Y
Carcinogenesis; 2020 Jul; 41(7):865-874. PubMed ID: 31738404
[TBL] [Abstract][Full Text] [Related]
32. Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.
Fujii T; Shimada K; Tatsumi Y; Tanaka N; Fujimoto K; Konishi N
Mol Carcinog; 2016 Sep; 55(9):1378-86. PubMed ID: 26259043
[TBL] [Abstract][Full Text] [Related]
33. MiRNAs from
Baulina N; Osmak G; Kiselev I; Popova E; Boyko A; Kulakova O; Favorova O
Cells; 2019 Feb; 8(2):. PubMed ID: 30743997
[TBL] [Abstract][Full Text] [Related]
34. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
35. DNMT3A epigenetically regulates key microRNAs involved in epithelial-to-mesenchymal transition in prostate cancer.
Mancini M; Grasso M; Muccillo L; Babbio F; Precazzini F; Castiglioni I; Zanetti V; Rizzo F; Pistore C; De Marino MG; Zocchi M; Del Vescovo V; Licursi V; Giurato G; Weisz A; Chiarugi P; Sabatino L; Denti MA; Bonapace IM
Carcinogenesis; 2021 Dec; 42(12):1449-1460. PubMed ID: 34687205
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
37. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
38. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
39. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis.
Benetatos L; Hatzimichael E; Londin E; Vartholomatos G; Loher P; Rigoutsos I; Briasoulis E
Cell Mol Life Sci; 2013 Mar; 70(5):795-814. PubMed ID: 22825660
[TBL] [Abstract][Full Text] [Related]
40. Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion.
Lempiäinen H; Couttet P; Bolognani F; Müller A; Dubost V; Luisier R; Del Rio Espinola A; Vitry V; Unterberger EB; Thomson JP; Treindl F; Metzger U; Wrzodek C; Hahne F; Zollinger T; Brasa S; Kalteis M; Marcellin M; Giudicelli F; Braeuning A; Morawiec L; Zamurovic N; Längle U; Scheer N; Schübeler D; Goodman J; Chibout SD; Marlowe J; Theil D; Heard DJ; Grenet O; Zell A; Templin MF; Meehan RR; Wolf RC; Elcombe CR; Schwarz M; Moulin P; Terranova R; Moggs JG
Toxicol Sci; 2013 Feb; 131(2):375-86. PubMed ID: 23091169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
